Cargando…
Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome, represen...
Autores principales: | Bahar, Mohammad W., Porta, Claudine, Fox, Helen, Macadam, Andrew J., Fry, Elizabeth E., Stuart, David I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794334/ https://www.ncbi.nlm.nih.gov/pubmed/33420068 http://dx.doi.org/10.1038/s41541-020-00267-3 |
Ejemplares similares
-
Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
por: Marsian, Johanna, et al.
Publicado: (2017) -
Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
por: Bahar, Mohammad W., et al.
Publicado: (2022) -
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
por: Bahar, Mohammad W., et al.
Publicado: (2022) -
Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals
por: Thomassen, Yvonne E., et al.
Publicado: (2013) -
Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris
por: Sherry, Lee, et al.
Publicado: (2022)